BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.610
-0.060 (-3.59%)
Jun 27, 2025, 4:00 PM - Market closed
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $12.08 million as of June 27, 2025. Its market cap has increased by 52.95% in one year.
Market Cap
12.08M
Enterprise Value
2.97M
1-Year Change
52.95%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since July 7, 2015, BioRestorative Therapies's market cap has decreased from $15.50M to $12.08M, a decrease of -22.05%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 12.50M | 26.26% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 7,500.00% |
| Dec 31, 2020 | 200.00K | - |
| Dec 31, 2019 | 200.00K | -97.87% |
| Dec 31, 2018 | 9.40M | -55.02% |
| Dec 29, 2017 | 20.90M | 39.33% |
| Dec 30, 2016 | 15.00M | 12.78% |
| Dec 31, 2015 | 13.30M | -14.19% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |